Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Microbiology
Fingerprint
Dive into the research topics where Weina Sun is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 45 Article
-
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge
Slamanig, S., Lemus, N., Lai, T. Y., Singh, G., Mishra, M., Abdeljawad, A., Boza, M., Dolange, V., Singh, G., Lee, B., González-Domínguez, I., Schotsaert, M., Krammer, F., Palese, P. & Sun, W., 25 Jan 2025, In: Vaccine. 45, 126586.Research output: Contribution to journal › Article › peer-review
-
Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico
López-Macías, C., Torres, M., Armenta-Copca, B., Wacher, N. H., Castro-Castrezana, L., Colli-Domínguez, A. A., Rivera-Hernández, T., Torres-Flores, A., Damián-Hernández, M., Ramírez-Martínez, L., la Rosa, G. P. D., Rojas-Martínez, O., Suárez-Martínez, A., Peralta-Sánchez, G., Carranza, C., Juárez, E., Zamudio-Meza, H., Carreto-Binaghi, L. E., Viettri, M. & Romero-Rodríguez, D. & 11 others, , 1 Jan 2025, In: Vaccine. 43, 126511.Research output: Contribution to journal › Article › peer-review
Open Access -
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in Brazil
Peixoto de Miranda, É. J. F., Calado, R. T., Boulos, F. C., de Sousa Moreira, J. A., Machado, F. F., Almeida, M. A. A. L. D. S., Da Rocha, M. C. O., Infante, V., Mercer, L. D., Hjorth, R., Scharf, R., White, J., Polyak, C., Raghunandan, R., García-Sastre, A., Sun, W., Palese, P., Krammer, F., Innis, B. & Pereira, C. G. & 1 others, , 11 Apr 2025, In: Vaccine. 52, 126680.Research output: Contribution to journal › Article › peer-review
-
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
Nguyen, Y. T. K., Zhu, X., Han, J., Rodriguez, A. J., Sun, W., Yu, W., Palese, P., Krammer, F., Ward, A. B. & Wilson, I. A., 19 Feb 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 7, e2416628122.Research output: Contribution to journal › Article › peer-review
Open Access -
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody
Atanasoff, K. E., Brambilla, L., Adelsberg, D. C., Kowdle, S., Stevens, C. S., Slamanig, S., Hung, C. T., Fu, Y., Lim, R., Tran, L., Allen, R., Sun, W., Duty, J. A., Bajic, G., Lee, B. & Tortorella, D., Jan 2024, In: mBio. 15, 1Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
Reports Summarize COVID-19 Findings from Icahn School of Medicine at Mount Sinai (A Surrogate Enzyme-linked Immunosorbent Assay To Select High-titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute ...)
Krammer, F., Palese, P., Simon, V. & Sun, W.
24/02/25
1 item of Media coverage
Press/Media
-
Findings from Icahn School of Medicine at Mount Sinai Yields New Data on Newcastle Disease Virus [A Single Immunization With Intranasal Newcastle Disease Virus (Ndv)-based Xbb.1.5 Variant Vaccine Reduces Disease and Transmission In Animals ...]
Lee, B., Krammer, F., Schotsaert, M., Palese, P. & Sun, W.
23/01/25
1 item of Media coverage
Press/Media
-
Reports from Icahn School of Medicine at Mount Sinai Highlight Recent Research in COVID-19 (A surrogate ELISA to select high titer human convalescent plasma for treating immunocompromised patients infected with SARS-CoV-2 variants of concern)
Krammer, F., Palese, P., Simon, V. & Sun, W.
17/01/25
1 item of Media coverage
Press/Media
-
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach.
Krammer, F., Palese, P. & Sun, W.
18/11/24
1 item of Media coverage
Press/Media